Showing results (1111-1120 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|August 17, 2020
Launch Delay of New Drugs in China and Effect on Patients' HealthXingyue Zhu, Bao LiuClinical Therapeutics|July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older PatientsEvelina Cardoso, Monia Guidi, Nihel Khoudour, et al.Clinical Therapeutics|April 12, 2023
Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical TrialBritte Beaudette-Zlatanova, Robert A Lew, John D Otis, et al.Clinical Therapeutics|April 17, 2021
Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort StudyJin Zhao, Feng Ma, Ming Bai, et al.Clinical Therapeutics|April 20, 2021
Economic Evaluation of New Oral Anticoagulants in Prevention of Venous Thrombosis Following Joint Replacement Surgery: A Systematic ReviewAziz Rezapour, Aghdas Souresrafil, Jalal ArablooClinical Therapeutics|April 9, 2021
The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the WorldRavi JhaveriClinical Therapeutics|September 11, 2007
Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisionsEli O MeltzerClinical Therapeutics|September 11, 2007
Acute pancreatitis in a patient treated with micafunginKen Sato, Minoru Hayashi, Mitsuyoshi Utsugi, et al.Clinical Therapeutics|September 11, 2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disordersMichael G Aman, Alexander A Vinks, Bart Remmerie, et al.Clinical Therapeutics|June 6, 2006
A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 yearsJay L Goldstein, James Aisenberg, Frank Lanza, et al.Pageof 677